L.L. Miller
- Molecular Biology
- Oncology top 10%
- Pulmonary and Respiratory Medicine top 10%
- Immunology top 10%
- Genetics
- Co-authors
- Gary ElfringR P MischakArchie KhentiganNancy WedelMaguy Del RioN A BrophyW. Scott HarkonenLynn E. S̄pitler
- Topics
- Muscle Physiology and Disorders (8 papers)Neutropenia and Cancer Infections (7 papers)Cancer therapeutics and mechanisms (6 papers)
- Cited by
- OncologyImmunologyBiotechnology
- Partner nations
- United StatesUnited KingdomIsrael
In The Last Decade
L.L. Miller
28 papers receiving 867 citations
Peers
Comparison fields: 5 of 85
- Molecular Biology 335
- Oncology 332
- Pulmonary and Respiratory Medicine 229
- Immunology 220
- Genetics 141
Countries citing papers authored by L.L. Miller
This map shows the geographic impact of L.L. Miller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L.L. Miller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L.L. Miller more than expected).
Fields of papers citing papers by L.L. Miller
This network shows the impact of papers produced by L.L. Miller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L.L. Miller. The network helps show where L.L. Miller may publish in the future.
Co-authorship network of co-authors of L.L. Miller
This figure shows the co-authorship network connecting the top 25 collaborators of L.L. Miller. A scholar is included among the top collaborators of L.L. Miller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L.L. Miller. L.L. Miller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 151 | |
| 3 | 12 | |
| 4 | 2 | |
| 5 | 2 | |
| 6 | 4 | |
| 7 | 5 | |
| 8 | 2 | |
| 9 | 5 | |
| 10 | 10 | |
| 11 | 7 | |
| 12 | 0 | |
| 13 | 11 | |
| 14 | 32 | |
| 15 | 48 | |
| 16 | 48 | |
| 17 | 22 | |
| 18 | 4 | |
| 19 | 21 | |
| 20 | 136 |
About L.L. Miller
L.L. Miller is a scholar working on Oncology, Molecular Biology and Neurology, having authored 30 papers that have together received 900 indexed citations. Recurring topics across this work include Muscle Physiology and Disorders (8 papers), Neutropenia and Cancer Infections (7 papers) and Cancer therapeutics and mechanisms (6 papers). The work is most often cited by research in Oncology (332 citations), Immunology (220 citations) and Biotechnology (78 citations). L.L. Miller has collaborated with scholars based in United States, United Kingdom and Israel. Frequent co-authors include Gary Elfring, R P Mischak, Archie Khentigan, Nancy Wedel, Maguy Del Rio, N A Brophy, W. Scott Harkonen, Lynn E. S̄pitler, William H. Sharfman and Kevin C. Conlon. Their work appears in journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.